Reminder for UroGen Pharma Ltd. Investors: Gross Law Firm Class Action Pending

Investors involved in the pending class action lawsuit have until July 28, 2025, to join as lead plaintiffs in the case against URGN. This information was announced on June 16, 2025, by PRNewswire.

The lawsuit alleges that URGN may have issued misleading or false statements regarding their business operations and prospects. These alleged misrepresentations may have led to artificially inflated stock prices. Investors who suffered financial losses as a result of these actions may be eligible to participate in the class action lawsuit.

URGN investors who purchased stock between a specified timeframe and have incurred financial losses are encouraged to join the lawsuit before the lead plaintiff deadline. Legal representation is available to assist investors in navigating the complexities of the legal process.

It is important for affected investors to act promptly to ensure their eligibility as lead plaintiffs in the case. By participating in the lawsuit, investors have the opportunity to potentially recover financial losses incurred due to the alleged misconduct of URGN.

Class action lawsuits provide an avenue for investors to seek justice and restitution for any damages they may have sustained as a result of fraudulent or deceptive practices. By working together as a unified group, investors can hold companies accountable for their actions and seek fair compensation for any harm caused.

Investors should carefully review the details of the pending class action lawsuit against URGN and consider their options for participation. Legal counsel can provide guidance and support throughout the process, helping investors understand their rights and navigate the legal system effectively.

The lead plaintiff deadline of July 28, 2025, is fast approaching, and investors are encouraged to take action promptly if they wish to participate in the lawsuit. By joining as lead plaintiffs, investors can play a key role in seeking justice and holding URGN accountable for any alleged misconduct that may have harmed their financial interests.